![]() MK-2 Inhibitor III structure
|
Common Name | MK-2 Inhibitor III | ||
---|---|---|---|---|
CAS Number | 1186648-22-5 | Molecular Weight | 358.393 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C21H18N4O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of MK-2 Inhibitor IIIMK-2 Inhibitor III (compound 16) is an orally active, selective, and ATP-competitive MAPKAP-K2 (MK-2) inhibitor with an IC50 of 0.85 nM, and is exceptional selectivity against MK-3 (IC50=0.21 μM), MK-5 (IC50=0.081 μM), ERK2 (IC50=3.44 μM), MNK1(IC50=5.7 μM) as well as CDK2, JNK2, IKK2, MSK1, and MSK2[1]. |
Name | 2-[2-(3-Quinolinyl)-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrate (1:1) |
---|---|
Synonym | More Synonyms |
Description | MK-2 Inhibitor III (compound 16) is an orally active, selective, and ATP-competitive MAPKAP-K2 (MK-2) inhibitor with an IC50 of 0.85 nM, and is exceptional selectivity against MK-3 (IC50=0.21 μM), MK-5 (IC50=0.081 μM), ERK2 (IC50=3.44 μM), MNK1(IC50=5.7 μM) as well as CDK2, JNK2, IKK2, MSK1, and MSK2[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.85 nM (MK-2), 0.21 μM (MK-3), 0.081 μM (MK-5), 3.44 μM (ERK2), 5.7 μM (MNK1)[1] |
In Vitro | MK-2 Inhibitor III suppresses TNFα production in U397 cells with an IC50 of 4.4 μM[1]. |
References |
Molecular Formula | C21H18N4O2 |
---|---|
Molecular Weight | 358.393 |
Exact Mass | 358.142975 |
Hazard Codes | Xi |
---|
2-[2-(3-Quinolinyl)-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrate (1:1) |
4H-Pyrrolo[3,2-c]pyridin-4-one, 1,5,6,7-tetrahydro-2-[2-(3-quinolinyl)-4-pyridinyl]-, hydrate (1:1) |